SlideShare a Scribd company logo
1
Lichen ruber verrucosus
in patients with chronic
venous insufficiency
Hana Zelenkova, M.D. Ph,D.
Private Clinic of Dermatovenereology,
DOST Svidnik, Slovakia
2
Chronic venous insufficiency
(CVI /CVO)
is a very common condition
of vayring severity, affecting 10 - 50% of
adult population
¾ of patients with CVO remain untreated
Pharmacological therapy is indicated
from the very first symptoms in order
to prevent progression
Pathological symptoms include oedema,
pain, heavy legs, cramps and cutaneous
changes
3
Lichen ruber verrucosus
Is very stressful for the patient
First treatment is provided usually after
severe changes and manifestations have
already occurred
Both genders are affected alike, but
women seek medical attention more often
The itching is unbearable, some patients
scratch the foci raw, and allegedly only
then feel partial relief
Clinical pattern - appears predominantly
on extensor areas of lower legs but also
on the ankles of patients suffering from
chronic venous insufficiency.
4
Lichen ruber verrucosus
(lichen planus hypertrophicus)
The most prominent clinical
manifestations include multiple firm
papule-like foci of pea size and
blending plaque-like foci in the size
of a human palm
Elevated foci show the nature of
hyperkeratosis verruciformis, and
are of purple-red to brown-red
colour, which appears mainly on
the margins, while towards the
centre the colour changes to
white (chalk hyperkeratosis).
5
Clinical manifestation
The manifestations itch
severely, and heal by forming
atrophic hyperpigmented
scars. In the areas affected by
verrucous lesions, chronic
irritation (scratching) may lead
to the development of
verrucous carcinoma. It is
therefore advisable to perform
a histological examination
6
Therapy
Systemic – should include topical antiflogistics
and corticoids together with occlusion and
compression dressings, retinoids, azelaic acid
Topical – venopharmacs, venotonics,
antihistamine drugs, exceptionally corticoids,
cyclosporine(?), Chlorochin (?) – secondary
undesired system effects
The therapy must respond to the extent of the
condition and the subjective trouble of the patient
Topical application of ointments or tinctures even
in combination with occlusion only brings partial
relief and is thus insufficient
7
Best effects are achieved with intra-focal
corticoid injections
The anamnesis must be thoroughly
inspected prior to injection!
Injection corticoids are contraindicated
in patients on oral anticoagulants, pregnant
women and are disputable in diabetics
Intrafocally administered 1-2 ml of drug
according to condition
One application is usually enough
If necessary, another dose is injected in 1
month
8
Lichen ruber verrucosus - Intra-focal
corticoid injections - before therapy
and after 1 session - 56–year-old female
before after
9
Lichen ruber verrucosus - Intra-focal corticoid
injections - before therapy and after 1 session
48-yer-old female, severely obese, treated
over 10 years due to lower leg oedema
before after
10
Conclusion
Lichen ruber verrucosus is a very
discomforting dermatosis, which is also
difficult to treat
In case of diagnostic problems opt
for histological examination (to
exclude malignancy)
Intrafocal application of corticoids is very
efficient
It brings instant relief and the pathology
is gradually reduced
It is up to the dermatologist and

More Related Content

What's hot

Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
Anjali Maheshwari
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
IE in the ccu
IE in the ccuIE in the ccu
IE in the ccu
Amir Mahmoud
 
Hydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid HemorrhageHydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid Hemorrhage
Ade Wijaya
 
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
ophthalmgmcri
 
DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017
imran zafar
 

What's hot (6)

Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
IE in the ccu
IE in the ccuIE in the ccu
IE in the ccu
 
Hydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid HemorrhageHydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid Hemorrhage
 
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
 
DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017
 

Viewers also liked

EWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand woundEWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand wound
EWMAConference
 
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
EWMAConference
 
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATIONEWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
EWMAConference
 
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
EWMAConference
 
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
EWMAConference
 
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial ProteasesEWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
EWMAConference
 

Viewers also liked (6)

EWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand woundEWMA 2013 - Ep575 - A case of diabetic hand wound
EWMA 2013 - Ep575 - A case of diabetic hand wound
 
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
EWMA 2013 - Ep502 - EVALUATION OF THE USE OF A POINT OF CARE TEST FOR PROTEAS...
 
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATIONEWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
EWMA 2013 - Ep496 - Diabetes Café - GROUP HEALTH EDUCATION
 
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
EWMA 2013 - EP428 - UTILIZATION OF STORE AND FORWARD DIGITAL TECHNOLOGY FOR T...
 
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
EWMA 2013 - Ep489 - Guidelines for the use of an incision management system a...
 
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial ProteasesEWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
EWMA 2013 - Ep508 - Effect of Collagen/ORC/Silver‐ORC on Bacterial Proteases
 

Similar to EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency

Cutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptxCutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptx
AlexXander53
 
Trends on management of superficial venous disease
Trends on management of superficial venous diseaseTrends on management of superficial venous disease
Trends on management of superficial venous disease
Shantonu Kumar Ghosh
 
sepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptxsepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptx
VenoshaGunasekaran
 
Behcet disease (2)
Behcet disease (2)Behcet disease (2)
Behcet disease (2)
Rajamarhamah
 
Viral Skin Infections.pptx
Viral Skin Infections.pptxViral Skin Infections.pptx
Viral Skin Infections.pptx
MohammedAhmed443334
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
DR RML DELHI
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
DR RML DELHI
 
chapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptxchapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptx
KhushalLahoti
 
Sepsis and rational use of abx
Sepsis and rational use of abxSepsis and rational use of abx
Sepsis and rational use of abx
Afiqi Fikri
 
Contrast reactions
Contrast reactionsContrast reactions
Contrast reactions
Sameer Peer
 
Posner Schlossman Syndrome
Posner Schlossman SyndromePosner Schlossman Syndrome
Posner Schlossman Syndrome
EllaHassanLee
 
Medical management of uveitis
Medical  management  of uveitisMedical  management  of uveitis
Medical management of uveitis
sri kiran eye institue
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
MirzaAnwarBaig1
 
Hypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptxHypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptx
SabonaLemessa2
 
Herpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptxHerpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptx
AmeyTamhane
 
FRAMBUSIA...........................................
FRAMBUSIA...........................................FRAMBUSIA...........................................
FRAMBUSIA...........................................
helixyap92
 
DRESS SYNDROME.pptx
DRESS SYNDROME.pptxDRESS SYNDROME.pptx
DRESS SYNDROME.pptx
LahariNaidu7
 
Herpetic eye disease
Herpetic eye diseaseHerpetic eye disease
Herpetic eye disease
Othman Al-Abbadi
 
lupus nephritis
lupus nephritislupus nephritis
lupus nephritis
Kushal Dp
 
MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptx
JibinJames35
 

Similar to EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency (20)

Cutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptxCutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptx
 
Trends on management of superficial venous disease
Trends on management of superficial venous diseaseTrends on management of superficial venous disease
Trends on management of superficial venous disease
 
sepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptxsepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptx
 
Behcet disease (2)
Behcet disease (2)Behcet disease (2)
Behcet disease (2)
 
Viral Skin Infections.pptx
Viral Skin Infections.pptxViral Skin Infections.pptx
Viral Skin Infections.pptx
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
 
chapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptxchapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptx
 
Sepsis and rational use of abx
Sepsis and rational use of abxSepsis and rational use of abx
Sepsis and rational use of abx
 
Contrast reactions
Contrast reactionsContrast reactions
Contrast reactions
 
Posner Schlossman Syndrome
Posner Schlossman SyndromePosner Schlossman Syndrome
Posner Schlossman Syndrome
 
Medical management of uveitis
Medical  management  of uveitisMedical  management  of uveitis
Medical management of uveitis
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Hypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptxHypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptx
 
Herpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptxHerpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptx
 
FRAMBUSIA...........................................
FRAMBUSIA...........................................FRAMBUSIA...........................................
FRAMBUSIA...........................................
 
DRESS SYNDROME.pptx
DRESS SYNDROME.pptxDRESS SYNDROME.pptx
DRESS SYNDROME.pptx
 
Herpetic eye disease
Herpetic eye diseaseHerpetic eye disease
Herpetic eye disease
 
lupus nephritis
lupus nephritislupus nephritis
lupus nephritis
 
MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptx
 

More from EWMAConference

EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMAConference
 
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMAConference
 
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMAConference
 
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMAConference
 
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case reportEWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMAConference
 
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMAConference
 
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMAConference
 
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMAConference
 
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMAConference
 
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMAConference
 
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMAConference
 
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigationEWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMAConference
 
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMAConference
 
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMAConference
 
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMAConference
 
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMAConference
 
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMAConference
 
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMAConference
 
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMAConference
 
Ep453 ewma p
Ep453 ewma pEp453 ewma p
Ep453 ewma p
EWMAConference
 

More from EWMAConference (20)

EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
EWMA 2013 - Ep590 - HOLIDAY FEET: MANAGING A SUNBURNT FOOT USING THE RIGHT DR...
 
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
EWMA 2013 - Ep589 - COST BENEFITS IN USING A MICROFIBER DEBRIDEMENT PAD IN TH...
 
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
EWMA 2013 - Ep 587 - TREATMENT OF DIABETIC FOOT WITH COMBINATION OF TOPICAL N...
 
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
EWMA 2013 - Ep580 - Treatment with negative pressure and drainage sheet for p...
 
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case reportEWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
EWMA 2013 - EP579 - Cancer and epidermolysis bullosa - case report
 
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
EWMA 2013 - Ep574 - SOFT SILICONE AND LINOLEIC ACID TO TREAT CHONICAL WOUND I...
 
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
EWMA 2013 - Ep573 - INCIDENCE OF EPIDERMOLYIS BULLOSA AMONG COUPLES WITH CONS...
 
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
EWMA 2013 - Ep570 - WHEN PERCEPTION IS NOT REALITY – LEG ULCER TREATMENT OF A...
 
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
EWMA 2013 - Ep566 - SEQUENTIAL TREATMENT OF CHRONIC WOUNDS WITH HYDRO-DESLOUG...
 
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
EWMA 2013 - Ep565 - TREATMENT OF PRESSURE ULCERS IN TOES WITH A NEW HYDRO-DES...
 
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
EWMA 2013 - Ep564 - DEVELOPING A TIME CONCEPT TREATMENT IN A POST-TRAUMATIC W...
 
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigationEWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
EWMA 2013 - Ep563 - A new anti-biofilm dressing: in vivo investigation
 
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
EWMA 2013 - Ep562 - MANAGEMENT OF AN ATYPICAL VASCULAR ULCER WITH TLC-NOSF DR...
 
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
EWMA 2013 - Ep559 - OUR EXPERIENCE IN THE HEALING OF TRAUMATIC WOUNDS WITH A ...
 
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
EWMA 2013 - Ep558 - USE OF A NEW HYDRO-DESLOUGHING ABSORBENT DRESSING* IN A N...
 
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
EWMA 2013 - Ep556 - A CASE OF MULTIPLE CUTANEOUS ESCHARS FROM PYODERMA GANGRE...
 
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
EWMA 2013 - Ep555 - Negatively Charged Microspheres- (NCM) Technology for The...
 
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
EWMA 2013 - Ep552 - THE USE OF URINARY BLADDER MATRIX (ACELL) IN THE TREATMEN...
 
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
EWMA 2013 - Ep547 - European wound-registry (EWR) -characteristics and method...
 
Ep453 ewma p
Ep453 ewma pEp453 ewma p
Ep453 ewma p
 

Recently uploaded

Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
Swastik Ayurveda
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
The Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in IndiaThe Best Ayurvedic Antacid Tablets in India
The Best Ayurvedic Antacid Tablets in India
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 

EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency

  • 1. 1 Lichen ruber verrucosus in patients with chronic venous insufficiency Hana Zelenkova, M.D. Ph,D. Private Clinic of Dermatovenereology, DOST Svidnik, Slovakia
  • 2. 2 Chronic venous insufficiency (CVI /CVO) is a very common condition of vayring severity, affecting 10 - 50% of adult population ¾ of patients with CVO remain untreated Pharmacological therapy is indicated from the very first symptoms in order to prevent progression Pathological symptoms include oedema, pain, heavy legs, cramps and cutaneous changes
  • 3. 3 Lichen ruber verrucosus Is very stressful for the patient First treatment is provided usually after severe changes and manifestations have already occurred Both genders are affected alike, but women seek medical attention more often The itching is unbearable, some patients scratch the foci raw, and allegedly only then feel partial relief Clinical pattern - appears predominantly on extensor areas of lower legs but also on the ankles of patients suffering from chronic venous insufficiency.
  • 4. 4 Lichen ruber verrucosus (lichen planus hypertrophicus) The most prominent clinical manifestations include multiple firm papule-like foci of pea size and blending plaque-like foci in the size of a human palm Elevated foci show the nature of hyperkeratosis verruciformis, and are of purple-red to brown-red colour, which appears mainly on the margins, while towards the centre the colour changes to white (chalk hyperkeratosis).
  • 5. 5 Clinical manifestation The manifestations itch severely, and heal by forming atrophic hyperpigmented scars. In the areas affected by verrucous lesions, chronic irritation (scratching) may lead to the development of verrucous carcinoma. It is therefore advisable to perform a histological examination
  • 6. 6 Therapy Systemic – should include topical antiflogistics and corticoids together with occlusion and compression dressings, retinoids, azelaic acid Topical – venopharmacs, venotonics, antihistamine drugs, exceptionally corticoids, cyclosporine(?), Chlorochin (?) – secondary undesired system effects The therapy must respond to the extent of the condition and the subjective trouble of the patient Topical application of ointments or tinctures even in combination with occlusion only brings partial relief and is thus insufficient
  • 7. 7 Best effects are achieved with intra-focal corticoid injections The anamnesis must be thoroughly inspected prior to injection! Injection corticoids are contraindicated in patients on oral anticoagulants, pregnant women and are disputable in diabetics Intrafocally administered 1-2 ml of drug according to condition One application is usually enough If necessary, another dose is injected in 1 month
  • 8. 8 Lichen ruber verrucosus - Intra-focal corticoid injections - before therapy and after 1 session - 56–year-old female before after
  • 9. 9 Lichen ruber verrucosus - Intra-focal corticoid injections - before therapy and after 1 session 48-yer-old female, severely obese, treated over 10 years due to lower leg oedema before after
  • 10. 10 Conclusion Lichen ruber verrucosus is a very discomforting dermatosis, which is also difficult to treat In case of diagnostic problems opt for histological examination (to exclude malignancy) Intrafocal application of corticoids is very efficient It brings instant relief and the pathology is gradually reduced It is up to the dermatologist and